Bad bugs. What you need to know about VRE/MRSA.
Lejeune
J R
JR
Children's Hospital of Pittsburgh, USA.
Berkowitz
D M
DM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control / Q000635:transmission; D004496:Education, Continuing; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007223:Infant; D017053:Infection Control / Q000379:methods* / Q000592:standards; D016106:Methicillin Resistance; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D013211:Staphylococcus aureus / Q000472:pathogenicity; D014481:United States; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents